Desfechos em Pacientes com Fenômeno de No-Reflow Coronário e a Relação entre a Molécula-1 de Lesão Renal e o Fenômeno de No-Reflow Coronário
Huyut, Mustafa Ahmet; Yamac, Aylin Hatice.
Arq. bras. cardiol
; 116(2): 238-247, fev. 2021. tab, graf
Artigo em Inglês, Português | LILACS | ID: biblio-1153012
Documentos relacionados
Outcomes in Coronary No-Reflow Phenomenon Patients and the Relationship between Kidney Injury Molecule-1 and Coronary No-Reflow Phenomenon.
Evaluation of Coronary Flow Level with Mots-C in Patients with STEMI Undergoing Primary PCI.
Comparison of the Outcomes between Coronary No-Reflow and Slow-Flow Phenomenon in Non-STEMI Patients.
The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis.
[Assessment of no-reflow phenomenon in patients with acute ST-elevation myocardial infarction].
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon.
Clinical significance of no-reflow in different stages of primary angioplasty among patients with acute myocardial infarctions.
Cardiac rehabilitation therapy for coronary slow flow phenomenon.
Administration of intracoronary adenosine before stenting for the prevention of no-reflow in patients with ST-elevation myocardial infarction.
Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization.